Caprock Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $422K | Buy |
28,398
+2,485
| +10% | +$37K | 0.01% | 783 |
|
|
2024
Q4 | $343K | Sell |
25,913
-8,391
| -24% | -$111K | 0.01% | 752 |
|
|
2024
Q3 | $488K | Buy |
34,304
+2,454
| +8% | +$34.9K | 0.02% | 574 |
|
|
2024
Q2 | $423K | Buy |
31,850
+2,830
| +10% | +$37.6K | 0.02% | 586 |
|
|
2024
Q1 | $403K | Sell |
29,020
-3,887
| -12% | -$54K | 0.02% | 477 |
|
|
2023
Q4 | $470K | Sell |
32,907
-34,369
| -51% | -$490K | 0.03% | 404 |
|
|
2023
Q3 | $1.04M | Buy |
67,276
+9,906
| +17% | +$153K | 0.08% | 201 |
|
|
2023
Q2 | $915K | Buy |
57,370
+13,620
| +31% | +$217K | 0.07% | 231 |
|
|
2023
Q1 | $721K | Buy |
43,750
+9,609
| +28% | +$158K | 0.06% | 266 |
|
|
2022
Q4 | $533K | Buy |
+34,141
| New | +$533K | 0.05% | 272 |
|
|
2022
Q2 | – | Sell |
-18,453
| Closed | -$264K | – | 627 |
|
|
2022
Q1 | $264K | Buy |
18,453
+3,216
| +21% | +$46K | 0.02% | 471 |
|
|
2021
Q4 | $208K | Buy |
15,237
+3,397
| +29% | +$46.4K | 0.02% | 533 |
|
|
2021
Q3 | $194K | Buy |
+11,840
| New | +$194K | 0.02% | 505 |
|
|
2021
Q2 | – | Sell |
-16,656
| Closed | -$304K | – | 556 |
|
|
2021
Q1 | $304K | Buy |
+16,656
| New | +$304K | 0.03% | 334 |
|
|
2020
Q4 | – | Sell |
-10,887
| Closed | -$194K | – | 490 |
|
|
2020
Q3 | $194K | Buy |
10,887
+469
| +5% | +$8.36K | 0.03% | 370 |
|
|
2020
Q2 | $190K | Buy |
+10,418
| New | +$190K | 0.03% | 375 |
|